Literature DB >> 21840963

Src kinase integrates PI3K/Akt and MAPK/ERK1/2 pathways in T3-induced Na-K-ATPase activity in adult rat alveolar cells.

Jianxun Lei1, David H Ingbar.   

Abstract

We previously reported that the 3,5,3'-triiodo-L-thyronine (T3)-induced increase of Na-K-ATPase activity in rat alveolar epithelial cells (AECs) required activation of Src kinase, PI3K, and MAPK/ERK1/2. In the present study, we assessed the role of Akt in Na-K-ATPase activity and the interaction between the PI3K and MAPK in response to T3 by using MP48 cells, inhibitors, and constitutively active mutants in the MP48 (alveolar type II-like) cell line. The Akt inhibitor VIII blocked T3-induced increases in Na-K-ATPase activity and amount of plasma membrane Na-K-ATPase protein. The Akt inhibitor VIII also abolished the increase in Na-K-ATPase activity induced by constitutively active mutants of either Src kinase or PI3K. Moreover, constitutively active mutants of Akt increased Na-K-ATPase activity in the absence of T3. Thus activation of Akt was required for T3-induced Na-K-ATPase activity in AECs and is sufficient in the absence of T3. Inhibitors of Src kinase (PP1), PI3K (wortmannin), and ERK1/2 (U0126) all blocked the T3-induced Na-K-ATPase activity. PP1 blocked the activation of PI3K and also ERK1/2 by T3, whereas U0126 did not prevent T3 activation of Src kinase or PI3K activity. Wortmannin did not significantly alter T3-increased MAPK/ERK1/2 activity, suggesting that T3-activated PI3K/Akt and MAPK/ERK1/2 pathways acted downstream of the Src kinase. Furthermore, in the absence of T3, a constitutively active mutant of Src kinase increased activities of Na-K-ATPase, PI3K, and MAPK/ERK1/2. A constitutively active mutant of PI3K enhanced Na-K-ATPase activity but did not alter the MAPK/ERK1/2 activity significantly. In summary, in adult rat AECs T3-stimulated Src kinase activity can activate both PI3K/Akt and MAPK/ERK1/2, and activation of Akt is necessary for T3-induced Na-K-ATPase activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21840963     DOI: 10.1152/ajplung.00151.2011

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  7 in total

1.  The free fatty acid receptor 1 promotes airway smooth muscle cell proliferation through MEK/ERK and PI3K/Akt signaling pathways.

Authors:  Atsuko Matoba; Nao Matsuyama; Sumire Shibata; Eiji Masaki; Charles W Emala; Kentaro Mizuta
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-11-02       Impact factor: 5.464

2.  20 (S)-ginsenoside Rh2 inhibits colorectal cancer cell growth by suppressing the Axl signaling pathway in vitro and in vivo.

Authors:  Haibo Zhang; Jun-Koo Yi; Hai Huang; Sijun Park; Wookbong Kwon; Eungyung Kim; Soyoung Jang; Si-Yong Kim; Seong-Kyoon Choi; Duhak Yoon; Sung-Hyun Kim; Kangdong Liu; Zigang Dong; Zae Young Ryoo; Myoung Ok Kim
Journal:  J Ginseng Res       Date:  2021-07-12       Impact factor: 5.735

3.  Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer.

Authors:  Wei Yu; Hongyan Chai; Ying Li; Haixia Zhao; Xianfei Xie; Hao Zheng; Chenlong Wang; Xue Wang; Guifang Yang; Xiaojun Cai; John R Falck; Jing Yang
Journal:  Toxicol Appl Pharmacol       Date:  2012-07-25       Impact factor: 4.219

Review 4.  Role of the type 2 iodothyronine deiodinase (D2) in the control of thyroid hormone signaling.

Authors:  Rafael Arrojo E Drigo; Tatiana L Fonseca; Joao Pedro Saar Werneck-de-Castro; Antonio C Bianco
Journal:  Biochim Biophys Acta       Date:  2012-08-29

5.  Claudin-1 expression confers resistance to anoikis in colon cancer cells in a Src-dependent manner.

Authors:  Amar B Singh; Ashok Sharma; Punita Dhawan
Journal:  Carcinogenesis       Date:  2012-08-31       Impact factor: 4.944

Review 6.  Thyroid hormone and P-glycoprotein in tumor cells.

Authors:  Paul J Davis; Sandra Incerpi; Hung-Yun Lin; Heng-Yuan Tang; Thangirala Sudha; Shaker A Mousa
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

7.  Dopamine receptor D2 regulates GLUA1-containing AMPA receptor trafficking and central sensitization through the PI3K signaling pathway in a male rat model of chronic migraine.

Authors:  Wei Zhang; Ming Lei; Qianwen Wen; Dunke Zhang; Guangcheng Qin; Jiying Zhou; Lixue Chen
Journal:  J Headache Pain       Date:  2022-08-10       Impact factor: 8.588

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.